A Metal Bare Stent With 125 Iodine (125I)Seeds for the Treatment of Malignant Central Airway Stenosis
Primary Purpose
Malignant Airway Obstruction
Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
stent implantation
Sponsored by
About this trial
This is an interventional treatment trial for Malignant Airway Obstruction
Eligibility Criteria
Inclusion Criteria:
- Age range: 18-75 years old, male or female who is not pregnant
- Comply with the diagnosis of malignant central airway stenosis, and undergo chest CT or bronchoscopy to confirm that the stenosis degree is above 50% and need to be implanted with airway metal stent; or the patient has obvious dyspnea due to airway stenosis, obstructive pneumonia
- Subjects voluntarily joined the study and signed informed consent, with good compliance and follow-up.
- Unable or refused surgery
- Unable or refused external radiation therapy
- Unable or refuse systemic tumor-related drugs therapy within 3 months
Exclusion Criteria:
- The distal end of the stenosis is unpredictable, and the stent treatment may not be satisfactory;
- Severe arrhythmia, acute myocardial ischemia, uncontrollable hypertensive crisis;
- Severe coagulopathy
- Severe organ dysfunction (except respiratory insufficiency)
- Allergic to anesthetics
- Airway fistula lesions
- The narrow lesion involves 2cm inside the glottis
- History of extrathoracic radiation therapy in the past 6 months
- Severe myelosuppression
Sites / Locations
- The first affiliated hospital of wenzhou medical university
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
A metal bare stent with 125I seeds
A metal bare stent
Arm Description
125I seeds fixed on the metal bare stent, then stent implantation
A metal bare stent implantation
Outcomes
Primary Outcome Measures
stenosis grade
Stenosis grade was classified as 5 grades on the cross-sectional CT imaging area: grade 0
= non-appreciable stenosis; grade 1, 2, 3, and 4 = 25, 50, 75, and 90% decrease in area, respectively; grade 5 = complete obstruction
stenosis grade
Stenosis grade was classified as 5 grades on the cross-sectional CT imaging area: grade 0
= non-appreciable stenosis; grade 1, 2, 3, and 4 = 25, 50, 75, and 90% decrease in area, respectively; grade 5 = complete obstruction
Secondary Outcome Measures
overall survival (OS)
overall survival
technical success
successful implantation of the stent across the stricture with appropriate positioning of the stent and full expansion
complications and side effects
Possible radiation related complications included neutropenia, decrease in IgA, IgG, and IgM, and leakage of radioactive seeds.Neutropenia was defined as a total white blood cell count b4000/mm3 in the plasma. The leakage of radioactive seeds was defined as the detection of non-target radioactive source verified by radiography
tumor growth rate
the size of tumor assessed by CT after stent implantation
the time of emergency endoscopic treatment
record the time of emergency endoscopic treatment for the recurrent severe dyspnea of patient
Full Information
NCT ID
NCT03944408
First Posted
May 5, 2019
Last Updated
May 8, 2019
Sponsor
First Affiliated Hospital of Wenzhou Medical University
Collaborators
Shanghai 10th People's Hospital, The Second Affiliated Hospital of Xiamen Medical College, Anhui Chest Hospital, China Meitan General Hospital, The Second Hospital of Hebei Medical University, West China Hospital, The Second Affiliated Hospital of Fujian Medical University, Wuhan Central Hospital, Wuhan No.1 Hospital, Hunan People's Hospital, First Affiliated Hospital of Chongqing Medical University, Yichang Central People's Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03944408
Brief Title
A Metal Bare Stent With 125 Iodine (125I)Seeds for the Treatment of Malignant Central Airway Stenosis
Official Title
The Efficacy and Safety of a Metal Bare Stent With 125I Seeds for the Treatment of Malignant Central Airway Compared to a Metal Bare Stent: A Multicentric Randomized Controlled Study.
Study Type
Interventional
2. Study Status
Record Verification Date
May 2019
Overall Recruitment Status
Unknown status
Study Start Date
May 2019 (Anticipated)
Primary Completion Date
July 2021 (Anticipated)
Study Completion Date
February 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
First Affiliated Hospital of Wenzhou Medical University
Collaborators
Shanghai 10th People's Hospital, The Second Affiliated Hospital of Xiamen Medical College, Anhui Chest Hospital, China Meitan General Hospital, The Second Hospital of Hebei Medical University, West China Hospital, The Second Affiliated Hospital of Fujian Medical University, Wuhan Central Hospital, Wuhan No.1 Hospital, Hunan People's Hospital, First Affiliated Hospital of Chongqing Medical University, Yichang Central People's Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Malignant central airway stenosis caused by primary or metastatic malignant tumor may lead to dyspnea even death of patients.With the rapid development of interventional pulmonology, bronchoscopic therapy has become the main treatment for malignant central airway stenosis. Metal stent implantation in airway can quickly relieve respiratory obstruction and improve quality of life.However, the tumor tissue can continue to grow into metal stent and obstruct airway again. This is the shortcoming of metal bare stents, which often need further treatment to keep airway open, including ablation, laser, cryotherapy, external radiotherapy or systemic anti-tumor drug therapy.Metal stent implantation combined with external radiotherapy can effectively reduce the incidence of airway restenosis.However, complications of external radiotherapy are high, including bone marrow suppression, radioactive pneumonia, radioactive esophagitis, myocardial injury and tracheoesophageal fistula, of which may cause serious consequences and even cause death of the patient.125I radioactive seeds have been one of the mature radioactive interventional therapy, which release X rays, and γ rays. Because of the short radioactive distance, 125I seeds can destruct tumor cells in tumor site and promote apoptosis and necrosis of tumor cells around the obstruction of the airway, meanwhile cause little damage to the surrounding normal tissues. Some studies showed that 125I seed implantation of lung tumor lesions achieved good short-term results.Therefore, the investigators hypothesize that 125I seeds fixed on the metal bare stent can not only improve the patient's breathing difficulties, but also play a role in killing tumor cells. At present, there have been reports of related clinical cases and monocentric control studies of malignant central airway stenosis treated with the implantation of metal stent with 125I seeds, but there is a lack of multicentric clinical studies with large samples.
Detailed Description
It is an open, multicentric randomized controlled clinical trial conducted in China, and plan to recruiting 200 patients who suffer malignant central airway stenosis. To evaluate the efficacy and safety of metal stent with 125I seeds group and metal bare stent group in the treatment of malignant central airway stenosis, follow-up should be done within 1 week, 1 month, and 3 months after the first treatment, followed by every 3 months. The contents include review of bronchoscopy and chest CT, blood routine, immune indicators (IgA, immunoglobulin M(Ig M), IgG), evaluation of general conditions. The patients of the first group need emission-computed tomography(ECT) imaging or positron emission tomography-computed tomography (PET-CT) examination within 1 month. If the patient has severe dyspnea, emergency bronchoscopy should be performed .
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malignant Airway Obstruction
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
A metal bare stent with 125I seeds
Arm Type
Experimental
Arm Description
125I seeds fixed on the metal bare stent, then stent implantation
Arm Title
A metal bare stent
Arm Type
Other
Arm Description
A metal bare stent implantation
Intervention Type
Procedure
Intervention Name(s)
stent implantation
Intervention Description
stent implantation
Primary Outcome Measure Information:
Title
stenosis grade
Description
Stenosis grade was classified as 5 grades on the cross-sectional CT imaging area: grade 0
= non-appreciable stenosis; grade 1, 2, 3, and 4 = 25, 50, 75, and 90% decrease in area, respectively; grade 5 = complete obstruction
Time Frame
the first month after stent implantation
Title
stenosis grade
Description
Stenosis grade was classified as 5 grades on the cross-sectional CT imaging area: grade 0
= non-appreciable stenosis; grade 1, 2, 3, and 4 = 25, 50, 75, and 90% decrease in area, respectively; grade 5 = complete obstruction
Time Frame
the third month after stent implantation
Secondary Outcome Measure Information:
Title
overall survival (OS)
Description
overall survival
Time Frame
From randomization until death (up to 24 months)
Title
technical success
Description
successful implantation of the stent across the stricture with appropriate positioning of the stent and full expansion
Time Frame
one week after stent implantation
Title
complications and side effects
Description
Possible radiation related complications included neutropenia, decrease in IgA, IgG, and IgM, and leakage of radioactive seeds.Neutropenia was defined as a total white blood cell count b4000/mm3 in the plasma. The leakage of radioactive seeds was defined as the detection of non-target radioactive source verified by radiography
Time Frame
From randomization until death (up to 24 months)
Title
tumor growth rate
Description
the size of tumor assessed by CT after stent implantation
Time Frame
From randomization until death (up to 24 months)
Title
the time of emergency endoscopic treatment
Description
record the time of emergency endoscopic treatment for the recurrent severe dyspnea of patient
Time Frame
From randomization until death (up to 24 months)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age range: 18-75 years old, male or female who is not pregnant
Comply with the diagnosis of malignant central airway stenosis, and undergo chest CT or bronchoscopy to confirm that the stenosis degree is above 50% and need to be implanted with airway metal stent; or the patient has obvious dyspnea due to airway stenosis, obstructive pneumonia
Subjects voluntarily joined the study and signed informed consent, with good compliance and follow-up.
Unable or refused surgery
Unable or refused external radiation therapy
Unable or refuse systemic tumor-related drugs therapy within 3 months
Exclusion Criteria:
The distal end of the stenosis is unpredictable, and the stent treatment may not be satisfactory;
Severe arrhythmia, acute myocardial ischemia, uncontrollable hypertensive crisis;
Severe coagulopathy
Severe organ dysfunction (except respiratory insufficiency)
Allergic to anesthetics
Airway fistula lesions
The narrow lesion involves 2cm inside the glottis
History of extrathoracic radiation therapy in the past 6 months
Severe myelosuppression
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chengshui Chen, doctor
Phone
86 13806889081
Ext
8613806889081
Email
wzchencs@163.com
First Name & Middle Initial & Last Name or Official Title & Degree
Xiaoxiao Lin, doctor
Phone
8615068252060
Ext
8615068252060
Email
295357950@qq.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Chengshui Chen, doctor
Organizational Affiliation
First Affiliated Hospital of Wenzhou Medical University
Official's Role
Study Chair
Facility Information:
Facility Name
The first affiliated hospital of wenzhou medical university
City
Wenzhou
State/Province
Zhejiang
ZIP/Postal Code
325000
Country
China
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
15187010
Citation
Ernst A, Feller-Kopman D, Becker HD, Mehta AC. Central airway obstruction. Am J Respir Crit Care Med. 2004 Jun 15;169(12):1278-97. doi: 10.1164/rccm.200210-1181SO.
Results Reference
result
PubMed Identifier
30254139
Citation
Ong P, Grosu HB, Debiane L, Casal RF, Eapen GA, Jimenez CA, Noor L, Ost DE. Long-term quality-adjusted survival following therapeutic bronchoscopy for malignant central airway obstruction. Thorax. 2019 Feb;74(2):141-156. doi: 10.1136/thoraxjnl-2018-211521. Epub 2018 Sep 25.
Results Reference
result
PubMed Identifier
12842534
Citation
Wood DE, Liu YH, Vallieres E, Karmy-Jones R, Mulligan MS. Airway stenting for malignant and benign tracheobronchial stenosis. Ann Thorac Surg. 2003 Jul;76(1):167-72; discussion 173-4. doi: 10.1016/s0003-4975(03)00033-x.
Results Reference
result
PubMed Identifier
14605078
Citation
Saad CP, Murthy S, Krizmanich G, Mehta AC. Self-expandable metallic airway stents and flexible bronchoscopy: long-term outcomes analysis. Chest. 2003 Nov;124(5):1993-9. doi: 10.1378/chest.124.5.1993.
Results Reference
result
PubMed Identifier
29538079
Citation
Sabath BF, Ost DE. Update on airway stents. Curr Opin Pulm Med. 2018 Jul;24(4):343-349. doi: 10.1097/MCP.0000000000000486.
Results Reference
result
PubMed Identifier
16039180
Citation
Lemaire A, Burfeind WR, Toloza E, Balderson S, Petersen RP, Harpole DH Jr, D'Amico TA. Outcomes of tracheobronchial stents in patients with malignant airway disease. Ann Thorac Surg. 2005 Aug;80(2):434-7; discussion 437-8. doi: 10.1016/j.athoracsur.2005.02.071.
Results Reference
result
PubMed Identifier
22516383
Citation
Rochet N, Hauswald H, Schmaus M, Hensley F, Huber P, Eberhardt R, Herth FJ, Debus J, Neuhof D. Safety and efficacy of thoracic external beam radiotherapy after airway stenting in malignant airway obstruction. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e129-35. doi: 10.1016/j.ijrobp.2011.11.055.
Results Reference
result
PubMed Identifier
24745612
Citation
Qu A, Wang H, Li J, Wang J, Liu J, Hou Y, Huang L, Zhao Y. Biological effects of (125)i seeds radiation on A549 lung cancer cells: G2/M arrest and enhanced cell death. Cancer Invest. 2014 Jul;32(6):209-17. doi: 10.3109/07357907.2014.905585. Epub 2014 Apr 18.
Results Reference
result
PubMed Identifier
29909977
Citation
Wang Y, Lu J, Guo JH, Zhu GY, Zhu HD, Chen L, Wang C, Teng GJ. A Novel Tracheobronchial Stent Loaded with 125I Seeds in Patients with Malignant Airway Obstruction Compared to a Conventional Stent: A Prospective Randomized Controlled Study. EBioMedicine. 2018 Jul;33:269-275. doi: 10.1016/j.ebiom.2018.06.006. Epub 2018 Jun 14.
Results Reference
result
PubMed Identifier
26171002
Citation
Lu M, Pu D, Zhang W, Liao J, Zhang T, Yang G, Liu Z, Singh S, Gao F, Zhang F. Trans-bronchoscopy with implantation of 125I radioactive seeds in patients with pulmonary atelectasis induced by lung cancer. Oncol Lett. 2015 Jul;10(1):216-222. doi: 10.3892/ol.2015.3204. Epub 2015 May 13.
Results Reference
result
PubMed Identifier
17157949
Citation
Mallick I, Sharma SC, Behera D. Endobronchial brachytherapy for symptom palliation in non-small cell lung cancer--analysis of symptom response, endoscopic improvement and quality of life. Lung Cancer. 2007 Mar;55(3):313-8. doi: 10.1016/j.lungcan.2006.10.018. Epub 2006 Dec 8.
Results Reference
result
PubMed Identifier
28389860
Citation
Wang Y, Guo JH, Zhu GY, Zhu HD, Chen L, Lu J, Wang C, Teng GJ. A Novel Self-Expandable, Radioactive Airway Stent Loaded with 125I Seeds: A Feasibility and Safety Study in Healthy Beagle Dog. Cardiovasc Intervent Radiol. 2017 Jul;40(7):1086-1093. doi: 10.1007/s00270-017-1639-8. Epub 2017 Apr 7.
Results Reference
result
Learn more about this trial
A Metal Bare Stent With 125 Iodine (125I)Seeds for the Treatment of Malignant Central Airway Stenosis
We'll reach out to this number within 24 hrs